July 11, 2026 10:30 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Foreign franchise league enters India! BBL opener to be played in Chennai, announce Modi-Albanese | 'They could have stopped me': Vijay blames police, former DMK government over Karur stampede | 'People will correct their 2025 mistake': Electoral debutant Prashant Kishor predicts BJP defeat in Bankipur | New assassination plot against Trump? Israel's secret intelligence raises alarm amid escalating Middle East tension | Ayatollah Ali Khamenei buried at Iran's holiest shrine as Middle East crisis deepens | Indian techie allegedly kills wife in US, sends photo of her body to 'secret girlfriend' in India; arrested | 'I fled the city': Thane doctor quits after alleged assault by Shiv Sena leader | Sensex surges 500 points before losing steam, ends marginally higher after volatile trading session | US court drops charges against Indian-origin doctor who drove Tesla off 250-foot cliff with family | Dalal Street bleeds! Sensex tanks over 1,600 points after Trump declares Iran ceasefire 'over'
Coronavirus Vaccine
Image Credit: Unsplash

UK kickstarts 'booster shot' trials with seven different Covid-19 vaccines: Report

| @indiablooms | May 20, 2021, at 07:03 am

London/IBNS: As fight against coronavirus is prolonged, mainly due to the more dangerous new variants of the contagion, the United Kingdom launched a nationwide study on Wednesday to find safety and efficacy of a third dose "booster" shot of Covid-19 vaccines in strengthening immunity against the deadly virus, according to a Reuters report.

The study will have 3,000 participants, who have already taken the two doses of coronavirus vaccine, and examine the effect of a third dose across seven different vaccines, the report said, adding that some of these vaccines are already in use while others are in the process of development.

The new study aims at exploring the possibility of a booster inoculation ahead of winter after initially targetting immunisation of the entire adult population with a two dose schedule by summer, the report informed.

The vaccines included in the trial are Pfizer, AstraZeneca and Moderna COVID-19 shots, which are already being administered in Britain, as well as vaccines from Johnson & Johnson, Novavax, Valneva and CureVac which the country will source in future, it said.

British health minister Matt Hancock said that the data accumulated in the trial will help shape the government to devise the plan for the booster programme later this year, the report added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.